查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1542479

全球生物樣本庫市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Biobanking Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 285 Pages | 商品交期: 最快1-2個工作天內

價格

全球生物樣本庫市場需求預計將從 2023 年的 578 億美元增至 2032 年的近 993.3 億美元，2024-2032 年研究期間複合年成長率為 6.2%。

生物樣本庫是指生物樣本和健康資訊的集合。不同的生物樣本庫收集不同類型的資訊和樣本，有些是特定於特定疾病或特定研究的，而有些是基於人群的。收集的樣本與描述樣本歷史、採樣方法、樣本處理和分析結果的資料清單相關聯，並用於開發新療法或新技術和科學出版物。生物庫有多種類型：以疾病為中心、基於人群、DNA/RNA、組織與多個樣本類型、商業、項目驅動和虛擬生物庫。

市場動態

醫療保健領域不斷成長的臨床試驗和研究以及研究人員不斷變化的需求預計將推動市場的發展。生物樣本庫正在發展成為一個潛在領域，因為精確和準確的結果收集在眾多研究中發揮著重要作用。這種不斷發展的成長是由基因組學、蛋白質組學和個人化醫療領域不斷發展的研究提供的。生物樣本庫中專門用於伴隨診斷和生物標記的樣本數量大幅增加。為了滿足不斷成長的需求，生物樣本庫和組織供應商的規模和數量都呈指數級成長，目前正在成為學術和商業團體的重要合作夥伴。同時，與生物樣本樣本採購和自動化成本高相關的問題正在阻礙市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球生物樣本庫市場的每個細分市場進行了包容性評估。生物樣本庫產業的成長和趨勢為本研究提供了整體方法。

市場區隔

生物樣本庫市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

  • 裝置
  • 耗材
  • 軟體與服務

依生物樣本類型

  • 血液製品
  • 人體組織
  • 細胞系
  • 核酸
  • 其他

按申請

  • 療法
  • 臨床診斷
  • 藥物發現與開發
  • 其他

依儲存類型

  • 手動的
  • 自動化

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲生物樣本庫市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。生物樣本庫市場的主要參與者包括Thermo Fisher Scientific Inc.、Tecan Group Ltd.、Qiagen NV、Hamilton Company、Brooks Automation、TTP Labtech Ltd.、VWR Corporation、Promega Corporation、Worthington Industries、Chart Industries、Becton、Dickinson And Company ，默克公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：生物銀行 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按生物樣本類型進行的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 按儲存類型分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球生物銀行市場分析：按產品

  • 概述（按產品）
  • 歷史和預測數據
  • 按產品分析
  • 裝置
  • 耗材
  • 軟體與服務

第 6 章：全球生物銀行市場分析：依生物樣本類型

  • 依生物樣本類型概述
  • 歷史和預測數據
  • 依生物樣本類型進行分析
  • 血液製品
  • 人體組織
  • 細胞系
  • 核酸
  • 其他

第 7 章：全球生物銀行市場分析：依應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 療法
  • 臨床診斷
  • 藥物發現與開發
  • 其他

第 8 章：全球生物銀行市場分析：按儲存類型

  • 按儲存類型概述
  • 歷史和預測數據
  • 按儲存類型分析
  • 手動的
  • 自動化

第 9 章：全球生物銀行市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：生物銀行公司的競爭格局

  • 生物樣本庫市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Tecan Group Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Qiagen NV
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Hamilton Company
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Brooks Automation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • TTP Labtech Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • VWR Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Promega Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Worthington Industries
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Chart Industries
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Becton
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Dickinson And Company
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Merck KGaA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11212372

The global demand for Biobanking Market is presumed to reach the market size of nearly USD 99.33 Billion by 2032 from USD 57.8 Billion in 2023 with a CAGR of 6.2% under the study period 2024-2032.

Biobanking refers to a collection of biological samples and health information. Different biobank collects different types of information and samples some are specific to a particular disease or specific research while some are population based. The collected samples are associated with a list of data describing sample history, sampling method, sample treatment, and the analysis outcomes and are used for the development of new treatments or new technologies and scientific publications. There are several types of biobanks: disease-centric, population-based, DNA/RNA, tissue versus multiple specimen type, commercial, project-driven, and virtual biobanks.

MARKET DYNAMICS

Growing clinical trials and research in the healthcare and changing needs of investigators is estimated to drive the market. Biobanking is evolving as a potential field as precise and accurate collection of outcomes plays an important role in a multitude of studies. The evolving growth is provided by growing research in the field of genomics, proteomics, and personalised medicine. Biobanks have experienced a huge rise in the number of samples specifically requested for companion diagnostic and biomarker. In response to growing demand, biobanks and tissue suppliers have grown exponentially in both size and number, and are now establishing as a key partner for academic and commercial groups. Meanwhile, issues associated with biospecimen sample procurement and high cost of automation is hampering the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Biobanking. The growth and trends of Biobanking industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Biobanking market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Equipment
  • Consumables
  • Software & Services

By Biospecimen Type

  • Blood Products
  • Human Tissues
  • Cell Lines
  • Nucleic Acids
  • Others

By Application

  • Therapeutics
  • Clinical Diagnostics
  • Drug Discovery & Development
  • Others

By Storage Type

  • Manual
  • Automated

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biobanking market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biobanking market include Thermo Fisher Scientific Inc., Tecan Group Ltd., Qiagen N.V., Hamilton Company, Brooks Automation, TTP Labtech Ltd., VWR Corporation, Promega Corporation, Worthington Industries, Chart Industries, Becton, Dickinson And Company, Merck KGaA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BIOBANKING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Biospecimen Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Storage Type
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOBANKING MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Equipment Historic and Forecast Sales By Regions
  • 5.5. Consumables Historic and Forecast Sales By Regions
  • 5.6. Software & Services Historic and Forecast Sales By Regions

6. GLOBAL BIOBANKING MARKET ANALYSIS BY BIOSPECIMEN TYPE

  • 6.1. Overview By Biospecimen Type
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Biospecimen Type
  • 6.4. Blood Products Historic and Forecast Sales By Regions
  • 6.5. Human Tissues Historic and Forecast Sales By Regions
  • 6.6. Cell Lines Historic and Forecast Sales By Regions
  • 6.7. Nucleic Acids Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL BIOBANKING MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Therapeutics Historic and Forecast Sales By Regions
  • 7.5. Clinical Diagnostics Historic and Forecast Sales By Regions
  • 7.6. Drug Discovery & Development Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL BIOBANKING MARKET ANALYSIS BY STORAGE TYPE

  • 8.1. Overview By Storage Type
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Storage Type
  • 8.4. Manual Historic and Forecast Sales By Regions
  • 8.5. Automated Historic and Forecast Sales By Regions

9. GLOBAL BIOBANKING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE BIOBANKING COMPANIES

  • 10.1. Biobanking Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF BIOBANKING INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Thermo Fisher Scientific Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Tecan Group Ltd.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Qiagen N.V.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Hamilton Company
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Brooks Automation
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. TTP Labtech Ltd.
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. VWR Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Promega Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Worthington Industries
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Chart Industries
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Becton
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Dickinson And Company
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Merck KGaA
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (Number of Doses (in Thousands) and USD MN)
  • Equipment Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Consumables Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Software & Services Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Analysis By Biospecimen Type (Number of Doses (in Thousands) and USD MN)
  • Blood Products Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Human Tissues Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Cell Lines Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Nucleic Acids Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Others Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Analysis By Application (Number of Doses (in Thousands) and USD MN)
  • Therapeutics Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Clinical Diagnostics Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Drug Discovery & Development Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Others Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Analysis By Storage Type (Number of Doses (in Thousands) and USD MN)
  • Manual Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Automated Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Global Biobanking Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • North America Market Analysis (Number of Doses (in Thousands) and USD MN)
  • United States Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Canada Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Mexico Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Europe Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Europe Market Estimate By Country (Number of Doses (in Thousands) and USD MN)
  • United Kingdom Market Analysis (Number of Doses (in Thousands) and USD MN)
  • France Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Germany Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Italy Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Russia Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Spain Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Rest of Europe Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Asia Pacific Market Analysis (Number of Doses (in Thousands) and USD MN)
  • China Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Japan Market Analysis (Number of Doses (in Thousands) and USD MN)
  • India Market Analysis (Number of Doses (in Thousands) and USD MN)
  • South Korea Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Australia Market Analysis (Number of Doses (in Thousands) and USD MN)
  • South East Asia Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Rest of Asia Pacific Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Latin America Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Brazil Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Argentina Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Peru Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Chile Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Rest of Latin America Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Middle East & Africa Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Saudi Arabia Market Analysis (Number of Doses (in Thousands) and USD MN)
  • UAE Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Israel Market Analysis (Number of Doses (in Thousands) and USD MN)
  • South Africa Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Rest of Middle East and Africa Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Biobanking Report
  • Market Research Process
  • Market Research Methodology
  • Global Biobanking Market Size, By Region (Number of Doses (in Thousands) and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Biospecimen Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Storage Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (Number of Doses (in Thousands) and USD MN)
  • Equipment Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Consumables Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Software & Services Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Global Market Analysis By Biospecimen Type (Number of Doses (in Thousands) and USD MN)
  • Blood Products Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Human Tissues Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Cell Lines Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Nucleic Acids Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Others Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Global Market Analysis By Application (Number of Doses (in Thousands) and USD MN)
  • Therapeutics Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Clinical Diagnostics Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Drug Discovery & Development Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Others Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Global Market Analysis By Storage Type (Number of Doses (in Thousands) and USD MN)
  • Manual Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Automated Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Global Market Sales (Number of Doses (in Thousands) and USD MN)
  • North America Market Sales (Number of Doses (in Thousands) and USD MN)
  • Europe Market Sales (Number of Doses (in Thousands) and USD MN)
  • Asia Pacific Market Sales (Number of Doses (in Thousands) and USD MN)
  • Latin America Market Sales (Number of Doses (in Thousands) and USD MN)
  • Middle East & Africa Market Sales (Number of Doses (in Thousands) and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.